Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pleiotropy01:33

Pleiotropy

41.9K
Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
41.9K
Glucose Transporters01:27

Glucose Transporters

26.4K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
26.4K
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

4.1K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.1K
Notch Signaling Pathway03:14

Notch Signaling Pathway

4.6K
The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
4.6K
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

470
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
470
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

511
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
511

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

RESCUE: An end-to-end multi-agent LLM system for proactive rare-disease patient screening in the EHR.

medRxiv : the preprint server for health sciences·2026
Same author

Hard to Halt: Automation Bias in Agent-Driven Sequencing Prior Authorization Workflows.

medRxiv : the preprint server for health sciences·2026
Same author

The Michigan Sibling Immunity Birth Study (M-SIBS): Study design protocol for a unique food allergy birth cohort.

The journal of allergy and clinical immunology. Global·2026
Same author

Transient aberrant plasma cells in a young patient with chronic inflammatory disease.

Blood·2026
Same author

Bi-allelic variants in the ribosomal protein RPS6KC1 cause a complex neurodevelopmental disorder.

American journal of human genetics·2026
Same author

Loss-of-function variants in MARK2 cause neurodevelopmental disorder.

HGG advances·2026

Related Experiment Video

Updated: Nov 5, 2025

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
06:41

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

Published on: August 20, 2019

13.9K

Neurodevelopmental phenotypes associated with pathogenic variants in SLC6A1.

Ashley Kahen1, Haluk Kavus2, Alexa Geltzeiler2

  • 1College of Dental Medicine, Columbia University, New York, New York, USA.

Journal of Medical Genetics
|May 19, 2021
PubMed
Summary

Pathogenic variants in SLC6A1 disrupt gamma-aminobutyric acid (GABA) transport, leading to neurodevelopmental disorders including hypotonia, intellectual disability, and seizures in affected individuals.

Keywords:
epilepsygeneticspediatrics

More Related Videos

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations
08:22

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations

Published on: December 1, 2017

8.8K
Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information
09:37

Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information

Published on: August 15, 2019

10.0K

Related Experiment Videos

Last Updated: Nov 5, 2025

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
06:41

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

Published on: August 20, 2019

13.9K
A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations
08:22

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations

Published on: December 1, 2017

8.8K
Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information
09:37

Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information

Published on: August 15, 2019

10.0K

Area of Science:

  • Neuroscience
  • Genetics
  • Molecular Biology

Background:

  • The SLC6A1 gene encodes GAT-1, a crucial gamma-aminobutyric acid (GABA) transporter in the brain.
  • GAT-1 regulates neurotransmitter homeostasis by clearing excess GABA from synaptic clefts.
  • Mutations in SLC6A1 impair GABA reuptake, causing neurobehavioral phenotypes.

Purpose of the Study:

  • To investigate the genotype-phenotype correlation in individuals with pathogenic SLC6A1 variants.
  • To characterize the clinical presentation associated with SLC6A1 disruptions.

Main Methods:

  • Collected data from 28 participants through medical history, seizure, and behavioral surveys.
  • Conducted clinical whole exome or gene panel sequencing for variant identification.
  • Included additional cases from medical literature for comprehensive analysis.

Main Results:

  • Identified 28 individuals with predominantly de novo pathogenic/likely pathogenic variants in SLC6A1.
  • Observed a higher prevalence of missense variants (71%) clustered in the GABA binding pocket.
  • Documented a consistent phenotype including hypotonia, intellectual disability, speech delay, autism spectrum disorder, sleep issues, and seizures.

Conclusions:

  • Pathogenic SLC6A1 variants are linked to a distinct clinical phenotype characterized by developmental delay, behavioral issues, and seizures.
  • Elucidating the genotype-phenotype relationship in SLC6A1 may facilitate the development of novel therapeutic strategies for GABA-related neurological conditions.